Brendan Foster will be at #Rockefeller in #NewYork tomorrow. Be sure to connect with him to learn more about our ability to synthesize custom #proteins for your discovery needs!
Tierra Biosciences
Biotechnology Research
San Leandro, California 4,263 followers
Speed, scale, and simplicity with protein on-demand
About us
Tierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Tierra’s first product, the Tierra Protein Platform, couples high-throughput protein manufacturing with the simplicity of e-commerce to make ordering custom proteins easier than ever before. By lowering the traditional protein synthesis barrier, Tierra serves scientists looking to change the world with novel proteins. Led by a team of protein experts, this fast-growing company is transforming the way people discover, screen, and develop proteins for future bio-based products. For more information, visit tierrabiosciences.com.
- Website
-
https://tierrabiosciences.com/
External link for Tierra Biosciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Leandro, California
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Synthetic Biology, Automation & Robotics, Cell-Free Systems, Big Data, Novel Products, High-throughput screening, Pharmaceutical, Biofuels, and Specialty Chemicals
Locations
-
Primary
San Leandro, California, US
Employees at Tierra Biosciences
-
Adam Sharkawy
Founder and Managing Partner, Material Impact, investor, company builder, entrepreneur, corp leader, but most importantly: someone who gives a damn
-
Jeff Kim
Co-Founder & CEO/President at Slingshot Biosciences
-
Corinna X. Chen
Venture capital partner in deep tech: synbio, next gen compute, biomaterials, climate tech
-
Zach Owyang
Senior Director, Manufacturing (Head)
Updates
-
Our scientists are excited to share our learnings across 100s of proteins assessed on the LabChip!
New speakers announced: 2024 Revvity Summit - Advanced Tools for Biologics Development! 📅 October 10 | 🕒 9:30 AM - 4 PM PT | 📍 South San Francisco (hybrid) Are you ready to dive into the latest advancements in biologics development? Connect with fellow scientists and industry leaders as they share their groundbreaking work on key R&D topics for advanced modalities. Our esteemed speakers from BioMarin Pharmaceutical Inc., Lyell Immunopharma, Novonesis, Soley Therapeutics, Sutro Biopharma, Inc., and Tierra Biosciences will be showcasing their innovative work, including: 🔬 Microfluidic capillary electrophoresis for biologics characterization 🧬 Advanced CHO-based expression systems 🏥 GMP ancillary materials for translational medicine development 🧪 Nucleic acid purification and automation 🤖 Integrated workstations to automate full biologics workflows Join us in-person or tune in virtually to learn, network, and be inspired by the cutting-edge developments in our field. See you there! 🔗 https://lnkd.in/eJ3h3n6m #RevvitySummit2024 #RevvUpResearch #BiologicsDevelopment #Innovation #Networking
-
Join Matt Zelinski at #UCSF in #MissionBay tomorrow to learn about how our platform can produce #proteins for your research needs! Get access to 1000s of proteins in just a few weeks!
-
#Tierra is #hiring a Platform Development Lead! Please reach out to us if you or anyone you know is interested in #engineering a #software and #hardware integrated #platform for protein synthesis! https://lnkd.in/gmQg4KQ8
Sr. Director / Vice President, Platform Development - Tierra Biosciences
apply.workable.com
-
Matt Zelinski will be at #UCDavis on Thursday. Be sure to connect with him to learn more about our ability to synthesize custom #proteins for your discovery needs!
-
In our latest blog, "A new era in targeted cancer therapy," we dive into how cell-free protein synthesis (CFPS) enables the discovery and development of antibody-drug conjugates (ADCs), making cancer treatments more effective and accessible. Highlights include: - Understanding the therapeutic landscape of ADCs. - Creating effective ADCs requires tackling challenges in targeting cancer cells, drug delivery, stability, and manufacturing. - How CFPS can support the development of next-generation ADCs. Discover how Tierra's technology is at the forefront of these innovations in targeted cancer therapy. Click here to read and download the blog. https://lnkd.in/gfS2Ps_M #Biologics #Immunotherapy #CancerTherapy #ADC #CFPS #Innovation #Protein #TierraBiosciences
Antibody-drug conjugates: A new era in targeted cancer therapy
tierrabiosciences.com
-
We enjoyed the conference as well! Thanks for highlighting our platform!
I wrote up a few highlights on last week's #SIMB meeting. There were fantastic talks and a lot of energy around natural product science, C1 biofuels, and protein-engineering/biocatalysis. Its a very exciting and fast-moving time to be in science and SIMB maintains its unique, quirky mix (thank you, organizers). Abridged Highlights: - Natural Products: Emily Mevers use of millipedes as a source on new neuroactive alkaloids.. - Biofuels: Benjamin M. Woolston exploration of combining anaerobic + aerobic organisms for single-reactor gas-fermentation of C1 feedstocks - Biocatalysis: John McIntosh gave an overview of a herculean effort of the #Merck biocat team to generate efficient multi-step cascade to create a large nucleoside drug. Very impressive. - Technology: Zachary Sun's Tierra Biosciences lets you order lyopholized protein in a tube in 2 weeks using cell-free reactions. Can order 100's. Can scale. Wildly enabling for small design shops. https://lnkd.in/e4KpRrkT
-
Join Matt Zelinski in #Chicago to learn about how our platform can produce #proteins for your research needs! Get access to 1000s of proteins in just a few weeks!
-
Adam D. Cohen will be in #Colorado next week for the 30th Protein Stability Conference. Be sure to connect with him to learn more about our ability to synthesize custom #proteins!
-
Our CSO and Founder, Zachary Sun, will be at #SIMB2024 in #Boston to present on #Tierra's platform that combines automated protein production and high-throughput data collection to improve predictability in protein synthesis.